Literature DB >> 18563708

Family-based association study between NOS-I and -IIA polymorphisms and autism spectrum disorders in Korean trios.

Hyo-Won Kim1, Soo-Churl Cho, Jae-Won Kim, In Hee Cho, Soon Ae Kim, Mira Park, Eun Jeong Cho, Hee-Jeong Yoo.   

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with a strong genetic component and environmental risk factors. Nitric oxide (NO), which is produced by nitric oxide synthase (NOS), may play a role in the development of ASD. We genotyped nine single nucleotide polymorphisms (SNPs) in the NOS-I gene and nine SNPs in the NOS-IIA gene and carried out the transmission disequilibrium test (TDT) and haplotype analysis in 151 Korean ASD trios. We found preferential transmission of the A allele of rs8068149 (P = 0.039) and G allele of rs1060826 (P = 0.035) of NOS-IIA in ASD and the haplotype analysis revealed that the two haplotypes had significant associations (P = 0.014 and 0.031, respectively). The behavioral subdomain score of failure to use nonverbal behaviors to regulate social interaction in Autism Diagnostic Interview-Revised (ADI-R) was significantly higher in subjects with the GG or AG allele in rs1060826 of NOS-IIA compared to those who had the AA allele (P = 0.027). These results provide significant but weak evidence for an association between NOS-IIA and ASD in the Korean population. 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18563708     DOI: 10.1002/ajmg.b.30798

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  10 in total

1.  A Role for Gene-Environment Interactions in Autism Spectrum Disorder Is Supported by Variants in Genes Regulating the Effects of Exposure to Xenobiotics.

Authors:  João Xavier Santos; Célia Rasga; Ana Rita Marques; Hugo Martiniano; Muhammad Asif; Joana Vilela; Guiomar Oliveira; Lisete Sousa; Ana Nunes; Astrid M Vicente
Journal:  Front Neurosci       Date:  2022-05-19       Impact factor: 5.152

2.  Necrosis is increased in lymphoblastoid cell lines from children with autism compared with their non-autistic siblings under conditions of oxidative and nitrosative stress.

Authors:  Penelope A E Main; Philip Thomas; Adrian Esterman; Michael F Fenech
Journal:  Mutagenesis       Date:  2013-07       Impact factor: 3.000

3.  Association of MET with social and communication phenotypes in individuals with autism spectrum disorder.

Authors:  Daniel B Campbell; Dana Warren; James S Sutcliffe; Evon Batey Lee; Pat Levitt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

4.  Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Authors:  Hitoshi Kuwabara; Hidenori Yamasue; Shinsuke Koike; Hideyuki Inoue; Yuki Kawakubo; Miho Kuroda; Yosuke Takano; Norichika Iwashiro; Tatsunobu Natsubori; Yuta Aoki; Yukiko Kano; Kiyoto Kasai
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 5.  An evo-devo approach to thyroid hormones in cerebral and cerebellar cortical development: etiological implications for autism.

Authors:  Pere Berbel; Daniela Navarro; Gustavo C Román
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-09       Impact factor: 5.555

6.  Commonality in dysregulated expression of gene sets in cortical brains of individuals with autism, schizophrenia, and bipolar disorder.

Authors:  Jinting Guan; James J Cai; Guoli Ji; Pak Chung Sham
Journal:  Transl Psychiatry       Date:  2019-05-24       Impact factor: 6.222

Review 7.  Genetic Factors of Nitric Oxide's System in Psychoneurologic Disorders.

Authors:  Regina F Nasyrova; Polina V Moskaleva; Elena E Vaiman; Natalya A Shnayder; Nataliya L Blatt; Albert A Rizvanov
Journal:  Int J Mol Sci       Date:  2020-02-26       Impact factor: 5.923

8.  Metabolic effects of sapropterin treatment in autism spectrum disorder: a preliminary study.

Authors:  R E Frye; R DeLatorre; H B Taylor; J Slattery; S Melnyk; N Chowdhury; S J James
Journal:  Transl Psychiatry       Date:  2013-03-05       Impact factor: 6.222

Review 9.  Treatments for biomedical abnormalities associated with autism spectrum disorder.

Authors:  Richard Eugene Frye; Daniel A Rossignol
Journal:  Front Pediatr       Date:  2014-06-27       Impact factor: 3.418

10.  A neuroligin-4 missense mutation associated with autism impairs neuroligin-4 folding and endoplasmic reticulum export.

Authors:  Chen Zhang; Jeff M Milunsky; Stephanie Newton; Jaewon Ko; Geping Zhao; Tom A Maher; Helen Tager-Flusberg; Marc F Bolliger; Alice S Carter; Antony A Boucard; Craig M Powell; Thomas C Südhof
Journal:  J Neurosci       Date:  2009-09-02       Impact factor: 6.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.